Assyro AI

Orange Book product · Brand (NDA)

XPHOZAH

TENAPANOR HYDROCHLORIDE

Brand (NDA)NDA 213931DISCN ARDELYX INC

At a glance

Oct 17, 2023

Approved

Brand (NDA)

Application

Not listed

TE code

8

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Oct 17, 2023

    2 yr 9 mo ago

  2. Today

  3. Exclusivity ends · NP

    New product exclusivity (3 years)

    Oct 17, 2026

    in 4 mo

  4. Patent 12016856 expires

    Listed drug substance patent expiration.

    Dec 30, 2029

    in 3 yr 7 mo

  5. Patent 8969377 expires

    Listed drug substance patent expiration.

    Dec 30, 2029

    in 3 yr 7 mo

  6. Patent 8541448 expires

    Listed drug substance patent expiration.

    Aug 01, 2033

    in 7 yr 3 mo

  7. Patent 10272079 expires

    Listed method-of-use patent (U-381) expiration.

    Apr 10, 2034

    in 7 yr 11 mo

  8. Patent 10272079 expires

    Listed method-of-use patent (U-3736) expiration.

    Apr 10, 2034

    in 7 yr 11 mo

  9. Patent 10940146 expires

    Listed method-of-use patent (U-381) expiration.

    Apr 10, 2034

    in 7 yr 11 mo

  10. Patent 10940146 expires

    Listed method-of-use patent (U-3736) expiration.

    Apr 10, 2034

    in 7 yr 11 mo

  11. Patent 12539299 expires

    Listed drug product patent expiration.

    Nov 26, 2042

    in 16 yr 8 mo

Pharmaceutical detail

Active ingredient

TENAPANOR HYDROCHLORIDE

Strength

EQ 10MG BASE

Dosage form

TABLET

Route

ORAL

TE code

Not listed

Application

NDA 213931

Product number

001

Marketing status

DISCN

Reference listed drug (RLD)

Yes

Reference standard (RS)

No

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Marketing exclusivity (1)

  • NPNew product exclusivity (3 years)

    Oct 17, 2026

    in 4 mo

Listed patents (8)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
12016856Dec 30, 2029in 3 yr 7 mo
SubstanceProduct
8969377Dec 30, 2029in 3 yr 7 mo
SubstanceProduct
8541448Aug 01, 2033in 7 yr 3 mo
SubstanceProduct
10272079Apr 10, 2034in 7 yr 11 mo
U-381
10272079Apr 10, 2034in 7 yr 11 mo
U-3736
10940146Apr 10, 2034in 7 yr 11 mo
U-381
10940146Apr 10, 2034in 7 yr 11 mo
U-3736
12539299Nov 26, 2042in 16 yr 8 mo
Product
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.